Medicare Enrolled
Dr. Paul Lin, MD
Hematology & Oncology · Wellington, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Paul Lin is a hematology & oncology in Wellington, FL, with 19 years in practice. Based on federal Medicare data, Dr. Lin performed 602,784 Medicare services across 3,758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $45,868 from 84 pharmaceutical and/or device companies across 1436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 0% volume in FL$ $45,868 industry payments
Medicare Practice Summary
Medicare Utilization ↗602,784
Medicare services
Top 0% in FL for hematology & oncology
3,758
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~31,725 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells | 267,660 | $0 | $1 |
| Iron infusion (Injectafer) | 165,000 | $1 | $2 |
| Filgrastim injection (Zarxio) for white blood cells | 51,060 | $0 | $1 |
| Iron infusion (Feraheme) | 43,350 | $0 | $3 |
| Epoetin alfa injection (Retacrit) for anemia | 35,230 | $6 | $13 |
| Denosumab injection (Prolia/Xgeva) | 10,620 | $17 | $28 |
| Immune globulin infusion (Gammagard) | 6,726 | $36 | $70 |
| Epoetin alfa injection (Procrit) for anemia | 3,840 | $6 | $25 |
| Complete blood count (CBC) with differential | 3,371 | $8 | $19 |
| Blood draw (venipuncture) | 2,983 | $8 | $10 |
| Dexamethasone injection (steroid) | 2,534 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,935 | $99 | $228 |
| Drug injection, under skin or into muscle | 1,804 | $11 | $31 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,520 | $1 | $23 |
| Office visit, established patient (20-29 min) | 1,432 | $70 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 512 | $51 | $150 |
| Infusion, normal saline solution, 250 cc | 457 | $1 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 447 | $23 | $66 |
| Injection of additional new drug or substance into vein | 365 | $12 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 280 | $16 | $45 |
| Administration of chemotherapy into vein, 1 hour or less | 263 | $105 | $294 |
| New patient office visit (45-59 min) | 222 | $129 | $348 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 178 | $58 | $105 |
| Injection, diphenhydramine hcl, up to 50 mg | 158 | $1 | $3 |
| Infusion into a vein for hydration, 31-60 minutes | 148 | $26 | $80 |
| Injection of drug or substance into vein | 145 | $29 | $82 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 113 | $1 | $12 |
| Drawing of blood for a medical problem | 79 | $75 | $213 |
| Infusion into a vein for hydration, each additional hour | 68 | $10 | $29 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $100 | $150 |
| Administration of chemotherapy into vein, each additional hour | 58 | $23 | $64 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 56 | $18 | $48 |
| Office visit, established patient, complex (40-54 min) | 51 | $134 | $306 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 23 | $1 | $8 |
| Infusion, normal saline solution , 1000 cc | 23 | $2 | $6 |
| Initial hospital admission, moderate complexity | 13 | $107 | $292 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.0% high complexity
62.3% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,868
Total received (2018-2024)
Avg $6,553/year across 7 years
Top 15% in FL for hematology & oncology
84
Companies
1,436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,007 (61.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,228 (35.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,634 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,542
2023$6,162
2022$5,479
2021$4,018
2020$2,902
2019$13,792
2018$8,973
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$10,884
Dova Pharmaceuticals
$4,082
US Oncology Corporate, Inc.
$2,763
AstraZeneca Pharmaceuticals LP
$2,702
Genentech USA, Inc.
$2,216
PFIZER INC.
$2,015
Incyte Corporation
$1,746
Novartis Pharmaceuticals Corporation
$1,477
Amgen Inc.
$1,363
E.R. Squibb & Sons, L.L.C.
$1,306
Lilly USA, LLC
$1,193
Janssen Biotech, Inc.
$1,171
Seagen Inc.
$1,145
GENZYME CORPORATION
$1,134
Merck Sharp & Dohme LLC
$840
Eisai Inc.
$757
Merck Sharp & Dohme Corporation
$651
Takeda Pharmaceuticals U.S.A., Inc.
$581
Daiichi Sankyo Inc.
$454
Astellas Pharma US Inc
$425
Pharmacyclics LLC, An AbbVie Company
$400
ABBVIE INC.
$394
EISAI INC.
$378
Regeneron Healthcare Solutions, Inc.
$356
Seattle Genetics, Inc.
$333
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
GlaxoSmithKline, LLC.
$295
PharmaEssentia USA Corporation
$271
Bayer HealthCare Pharmaceuticals Inc.
$253
AMAG Pharmaceuticals, Inc.
$238
JAZZ PHARMACEUTICALS INC.
$228
Exelixis Inc.
$213
SANOFI-AVENTIS U.S. LLC
$200
SEAGEN INC.
$189
ARRAY BIOPHARMA INC
$181
EMD Serono, Inc.
$147
Global Blood Therapeutics, Inc.
$122
Mirati Therapeutics, Inc.
$121
PUMA BIOTECHNOLOGY, INC.
$114
Rigel Pharmaceuticals, Inc.
$112
Gilead Sciences, Inc.
$109
Alexion Pharmaceuticals, Inc.
$108
AbbVie, Inc.
$107
Verastem, Inc.
$101
Foundation Medicine, Inc.
$101
AbbVie Inc.
$100
Pharmacosmos Therapeutics Inc.
$85
Puma Biotechnology, Inc.
$79
Otsuka America Pharmaceutical, Inc.
$76
Amneal Pharmaceuticals LLC
$68
Ipsen Biopharmaceuticals, Inc
$66
MEDIVATION FIELD SOLUTIONS LLC
$63
Kite Pharma, Inc.
$63
SOBI, INC
$52
Deciphera Pharmaceuticals Inc.
$51
Agios Pharmaceuticals, Inc.
$51
Pharmacyclics LLC, an AbbVie Company
$49
Azurity Pharmaceuticals, Inc.
$44
Mylan Institutional Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
TAIHO ONCOLOGY, INC.
$41
BeiGene USA, Inc.
$41
Sandoz Inc.
$39
TG THERAPEUTICS, INC.
$37
Janssen Pharmaceuticals, Inc
$36
Sobi, Inc
$35
Stemline Therapeutics Inc.
$34
Adaptive Biotechnologies Corporation
$33
INSYS Therapeutics Inc
$31
Organon LLC
$31
ADC Therapeutics America, Inc.
$27
Dendreon Pharmaceuticals LLC
$26
SERVIER PHARMACEUTICALS LLC
$24
Kyowa Kirin, Inc.
$24
Abbott Laboratories
$24
Genmab U.S., Inc.
$23
Aveo Pharmaceuticals, Inc.
$23
NOVARTIS PHARMACEUTICALS CORPORATION
$20
Octapharma USA, Inc.
$17
Karyopharm Therapeutics Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$15
Spectrum Pharmaceuticals Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
PORTOLA PHARMACEUTICALS, INC.
$11
Top 3 companies account for 38.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · Abraxane · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · EnSite X · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SYNDROS · Stivarga · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZARXIO · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
43
Per 100K population
2.9
County median income
$81,115
Nearest hospital
WELLINGTON REGIONAL MEDICAL CENTER
5.8 mi
5.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lin is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 15%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Lin performed 267,660 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $45,868 from 84 companies across 1,436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other hematology & oncologys in Wellington?
Dr. Lin's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Wellington
Browse hematology & oncologys in Wellington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology